13F Portfolios

PAULSON & CO. INC. 13F: Quarter-over-Quarter Portfolio Changes

PAULSON & CO. INC. reported a disclosed portfolio value of approximately $3.1 billion in its latest SEC Form 13F-HR filing for Q1 2026, down 4.6% quarter on quarter. Over the quarter, the fund initiated 1 new position, bought more shares in 2 holdings, trimmed 1 holding, and exited 1 position.

PAULSON & CO. INC.'s top buy was Thryv Hldgs INC (THRY) . The fund bought 94.2% more shares, lifting the position's portfolio weight by -0.1 percentage points. Its top sell was Madrigal Pharmaceuticals INC (MDGL) . The fund sold 18.5% of its previously reported shares, reducing the position's portfolio weight by 7.1 percentage points.

New PositionsQ1 2026

Securities disclosed for the first time in Q1 2026 that were not present in the prior 13F-HR filing.

PAULSON & CO. INC. new positions in Q1 2026, representing first-time disclosed long equity stakes
CompanyTickerInitial Portfolio WeightHistory
AMICUS THERAPEUTICFOLD0.0%History →

Top BuysQ1 2026

The fund's top buys among existing positions in Q1 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.

PAULSON & CO. INC. top buys in existing positions in Q1 2026
CompanyTickerPortfolio Weight ChangeMore SharesHistory
THRYV HLDGS INCTHRY+-0.1%+94.2%History →
INTERNATIONAL TOWER HILL MINTHM+3.4%+41.8%History →

Top SellsQ1 2026

The fund's top sells among positions it retained in Q1 2026. Ranked by portfolio-weight impact. Full exits are listed separately.

PAULSON & CO. INC. top sells in existing positions in Q1 2026
CompanyTickerPortfolio Weight ChangeShares SoldHistory
MADRIGAL PHARMACEUTICALS INCMDGL-7.1%18.5%History →

Full ExitsQ1 2026

Positions present in the prior 13F-HR filing that no longer appear in Q1 2026.

PAULSON & CO. INC. full exits in Q1 2026
CompanyTickerLast-Reported Portfolio Weight
SOLSTICE ADVANCED MATLS INCSOLS2.1%
Latest

Net Portfolio Value ChangeQ1 2026

  • $3.3B
    Prior quarter
  • $3.1B
    Current quarter
  • $-0.2B
    Net delta
  • -4.6%
    % change

Methodology & FAQ

How PAULSON & CO. INC. Quarterly Changes Are Computed

All deltas are sourced from sequential SEC Form 13F-HR filings for PAULSON & CO. INC.: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description — including how confidential treatment filings are handled — is documented in the Methodology.

What stocks did PAULSON & CO. INC. buy in Q1 2026?

In Q1 2026, PAULSON & CO. INC. initiated 1 new position (AMICUS THERAPEUTIC (FOLD)); bought more shares of THRYV HLDGS INC (THRY), INTERNATIONAL TOWER HILL MIN (THM).

What stocks did PAULSON & CO. INC. sell in Q1 2026?

In Q1 2026, PAULSON & CO. INC. fully sold 1 position (SOLSTICE ADVANCED MATLS INC (SOLS)); reduced holdings in MADRIGAL PHARMACEUTICALS INC (MDGL).

Which positions did PAULSON & CO. INC. initiate in Q1 2026?

PAULSON & CO. INC. established 1 new position in Q1 2026: AMICUS THERAPEUTIC (FOLD, 0.0%).

Which existing positions saw the largest allocation increases for PAULSON & CO. INC. in Q1 2026?

Of 2 existing positions with share-count increases in Q1 2026, the largest were: THRYV HLDGS INC (THRY, +-0.1% weight, +94.2% shares), INTERNATIONAL TOWER HILL MIN (THM, +3.4% weight, +41.8% shares).

Which positions did PAULSON & CO. INC. fully exit in Q1 2026?

PAULSON & CO. INC. fully exited 1 position in Q1 2026: SOLSTICE ADVANCED MATLS INC (SOLS, last-reported weight 2.1%).

Which existing positions saw the largest allocation reductions for PAULSON & CO. INC. in Q1 2026?

Of 1 existing position with share-count reductions in Q1 2026, the largest were: MADRIGAL PHARMACEUTICALS INC (MDGL, -7.1% weight, -18.5% shares).

Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?

No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.